Advertisement

Topics

Virtualized Evolved Packet Core vEPC Market by Component Solution Service, Deployment Type Cloud OnPremises, EndUser Telecom Operator Enterprise, Use Cases LTE, Volte, VoWiFi; BWA, IoT M2M, MPN MVNO, and Region Global Forecast to 2022 [Report Updat

02:50 EST 25 Jan 2018 | BioPortfolio Reports

Rapid increase in the number of mobile LongTerm Evolution LTE subscribers across the globe is driving the growth of the virtualized Evolved Packet Core vEPC market.

The global vEPC market size is expected to grow from USD 968.9 million in 2017 to USD 7,975.3 million by 2022, at a Compound Annual Growth Rate CAGR of 52.4 % during the forecast period. The global growth of network infrastructure, increase in LTE mobile subscribers, and lower in Capital Expenditure CapEx and Operational Expenditure OpEx are some of the factors expected to drive the growth of the vEPC market. However, reluctance in transiting from legacy infrastructure to virtualization may hinder the market growth of the vEPC market.

The cloud deployment type is expected to grow at a higher rate during the forecast period.

The cloud deployment type is one of most effective technologies that impact every line of business. Enterprises and telecom operators are adopting cloudbased vEPC solutions at a rapid pace due to the wide range of features, such as reliability, scalability, flexibility, and low costs. The cloudbased vEPC design offers distributed, stateless, and clustered elements, resulting in better performance and availability. The overall adoption of cloudbased solutions is in its nascent stage and is expected to grow significantly during the forecast period.

LTE, VoLTE, and VoWiFi is expected to have the largest market share during the forecast period.

MNOs are utilizing vEPC solution on their mobile core network to deliver the LTE, Voice over LTE VoLTE, and Voice over WiFi VoWiFi service for mobile subscribers. The virtualizing core network is very economical for operators compared to traditional EPC solutions. Additionally, VoWiFi also functions on same mobile core network as VoLTE. Mobile operators are delivering WiFi calling service to customers in low network coverage area. Several operators have deployed vEPC to extend VoLTE and VoWiFi services for customers across the globe, and this trend is expected to continue during the forecast period.


Asia Pacific APAC is expected to grow at the highest CAGR during the forecast period.

In terms of growth rate, APAC will be growing at the highest growth rate. Mobile operators in Japan, South Korea, and China are the early adopters of the vEPC solution. For example, SK Telecom, SoftBank, and China Mobile have implemented virtualized network components on their network for VoLTE, IoT, and Machine to Machine M2M communication. Majority of operators and enterprises in the APAC region are still using traditional EPC solution and wave is expected to shift towards vEPC solutions.


Indepth interviews were conducted with Chief Executive Officers CEOs, marketing directors, innovation and technology directors, and executives from various key organizations operating in the vEPC market.

The breakup of the profiles of the primary participants is given below:

By Company: Tier 1 25%, Tier 2 41%, and Tier 3 34%

By Designation: CLevel 53%, Director Level 43%, and Others 4%

By Region: North America 42%, Europe 24%, APAC 30%, and Rest of the World RoW 4%

The key vEPC vendors profiled in the report are as follows:

1. Affirmed Networks US

2. Ericsson Sweden

3. Huawei Technologies China

4. Mavenir US

5. ZTE Corporation China

6. Athonet Italy

7. Cisco SystemsUS

8. NEC Corporation Japan

9. Nokia Corporation Finland

10. Samsung South Korea

The key innovators profiled in the report are as follows:

11. ExteNet Systems US

12. Telrad Networks Israel

13. Core Network Dynamics Germany

Research Coverage

The vEPC market has been segmented on the basis of components solutions and services, deployment types, endusers, use cases, and regions. A detailed analysis of the key industry players has been done to provide insights into their business overview; products and services; key strategies; new product launches; partnerships, agreements, and collaborations; expansions; and competitive landscapes associated with the global vEPC market.


Reasons to Buy the Report

The report will help market leaders/new entrants in the following ways:

The report segments the vEPC market comprehensively and provides the closest approximations to the revenue numbers for the overall market and subsegments across different regions

The report is expected to help stakeholders understand the pulse of the market and provides the information on the key market drivers, restraints, challenges, and opportunities

The report is expected to help stakeholders understand their competitors better and gain more insights to enhance their position in the market. The competitive landscape section includes competitor ecosystem, new product developments, partnerships, and mergers and acquisitions

Original Article: Virtualized Evolved Packet Core vEPC Market by Component Solution Service, Deployment Type Cloud OnPremises, EndUser Telecom Operator Enterprise, Use Cases LTE, Volte, VoWiFi; BWA, IoT M2M, MPN MVNO, and Region Global Forecast to 2022 [Report Updat

NEXT ARTICLE

More From BioPortfolio on "Virtualized Evolved Packet Core vEPC Market by Component Solution Service, Deployment Type Cloud OnPremises, EndUser Telecom Operator Enterprise, Use Cases LTE, Volte, VoWiFi; BWA, IoT M2M, MPN MVNO, and Region Global Forecast to 2022 [Report Updat"

Quick Search
Advertisement

 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...